1. Erdös, E.G. (1979) In: Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology (Erdös,E.G., ed) Vol.25 (Suppl), 427–487.
2. Bokish, V.A. and Müller-Eberhard, H.J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest 1970; 49: 2427 2436.
3. Hugli, T., Gerard, C., Kawahara, M., Scheetz, M., Barton, R., Bruggs, S., Koppel, G. and Russell, S. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem 1981; 41: 59–66.
4. Belew, M., Gerdin, B., Lindeberg, G., Porath, J, and Wallin, R. Structural-activity relationships of vasoactive peptides derived from fibrin or fibriongen degraded by plasmin. Biochim Biophys Acta 1980; 621: 169–178.
5. Perryman, M., Knell, D.and Roberts, R. Molecular mechanism for the production of multiple forms of MM creatine kinase. Clin Chem 1984; 30: 662–664.